Ampac Fine Chemicals will use Codexis' proprietary biocatalysis technology to develop lower cost, more efficient and lower environmental impact processes for pharmaceutical intermediates and APIs.
PR Newswire
Monday, 29 March 2010
Ampac confirms manufacturing deal with Codexis
Lonza cuts jobs in Visp
Lonza continues to announce measures to meet the cutbacks announced last year. The company plans to cut fixed costs in Basel and Visp by CHF40m over the next 18 months, which will include 193 jobs at Visp.
Lonza
Wednesday, 24 March 2010
Borgas rebrands fine chemicals
Speaking at the Socma dinner in New York, Lonza CEO, Stefan Borgas, said that the industry needed to consider itself the "fine molecules" sector as the products it makes are no longer just chemicals. He said the future of the industry lay in companies reinventing their current business models and taking a more collaborative approach to innovation.
Icis
Thursday, 18 March 2010
Wednesday, 17 March 2010
Successful audits for Jubilant facilities
Jubilant Organosys' Hollister-Stier's Spokane, WA, facility completed a successful audit by the Japanese Pharmaceutical and Medical Device Agency (PMDA) and its Draxis Pharma Montreal, Canada, facility completed a successful audit by the US FDA and Health Canada.
Hollister-Stier
UKTI and Chemspec Europe
UKTI and Chemspec Europe
UK Trade & Investment is co-ordinating a UK pavillion at Chemspec Europe in June. Grants are available to potential exhibiters. Contact Tricia Francis for more details.
Sunday, 14 March 2010
AutekBio to establish Chinese biologics facility
AutekBio, SUMA Ventures and Beijing E-Town Harvest International Capital Management Corporation will jointly invest $100m to develop a new biopharmaceutical contract manufacturing organisation in China. The joint venture will build an R&D and manufacturing center in southern Beijing with up to 20,000L capacity in multiple trains.
Business Wire
Partnership offers CMC services
Cambridge Major Laboratories has teamed up with Avantium Pharma, Xcelience and Beckloff Associates to offer an expedited CMC solutions program designed to accelerate drug development. The service is available to companies ranging from small biotechs to big pharma.
Fierce Pharma Manufacturing
Wacker refocusses pharma-facing activities; opens biologics plant
Wacker Chemie has restructured its biotech and fine-chemical segment. The Wacker Biosolutions division, formerly known as Wacker Fine Chemicals, will focus on services for the food, pharmaceuticals and agrochemicals sectors alongside its existing portfolio of fine chemicals and chemical intermediates. Additionally, Wacker has opened a new €18m GMP-certified biologics facility in Jena, Germany, to enable the company to accommodate its customers’ rapidly growing demand for biotechnologically manufactured pharmaceuticals.
Wacker
In-Pharma Technologist
Aurobindo company launches CRAMS subsidiary
Indian pharmaceutical company Aurobindo Pharma has launched a subsidiary to provide CRAMS services. AuroSource will partner with global large, mid-sized and emerging biotech and pharmaceutical companies.
In-Pharma Technologist
Thursday, 4 March 2010
Wednesday, 3 March 2010
Tuesday, 2 March 2010
Dishman's Shanghai facility delayed
Dishman Chemicals and Pharmaceuticals Shanghai, China, facility has been further delayed by a couple of months. VVS Murthy, chief financial officer, expects the facility to start functioning from the second half of 2010, maybe August-September 2010. Dishman has invested $10m in the project.
DNA India
Subscribe to:
Posts (Atom)
